Pulmonary veno-occlusive disease presenting with recurrent pulmonary oedema and the use of nitric oxide to predict response to sildenafil.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 18820120.
- Also identified by DOI 10.1136/thx.2007.088831.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Pulmonary veno-occlusive disease (PVOD) is a disorder which causes progressive pulmonary hypertension, usually presenting with worsening dyspnoea and right heart failure. Pulmonary oedema induced by pulmonary vasodilator therapy to reduce pulmonary arterial pressure has been well described in PVOD, but here we describe a case of PVOD presenting with recurrent episodes of acute non-cardiogenic pulmonary oedema, in the absence of significant pulmonary hypertension. Concern over the risk of precipitating pulmonary oedema led us to use inhaled nitric oxide to predict the safety and efficacy of sildenafil.
Medical subject headings
- Bronchodilator Agents
- Nitric Oxide
- Piperazines
- Pulmonary Edema
- Pulmonary Veno-Occlusive Disease
- Sulfones
- Vasodilator Agents